PHA-Exch> Medicines for all

[Claudio Schuftan]

   From:    ekbalb at gmail.com
   Subject:  new publication med4all
   From: Christian Wagner-Ahlfs <cwagner at bukopharma.de>

New publication: Medical research:  Science in the public interest


Brochure explains new licensing models for publicly funded drug research


Public funding often plays a key role in R&D of new medicines. But such
innovative drugs are often not affordable for people in poor countries. How
can access to these publicly-funded medical innovations be secured for as
many people as possible? How can we in particular improve access to medicine
for people in developing countries? One possible solution to this challenge
could come with the concept of "Equitable Licensing". Equitable licenses,
examples of which have been developed by legal experts and universities in
the USA, are specific licenses for the technology transfer between public
institutions and the pharmaceutical industry.

This brochure presents background information about challenges in the drug
supply for poor countries. Numerous case studies show the US experience with
new licensing models and highlight possible approaches for the specific
German setting.

Editor: BUKO Pharma-Kampagne, Institut für Sozialmedizin, Epidemiologie und
Gesundheitsökonomie Charité-Universitätsmedizin Berlin, Zentrum für
Europäische Rechtspolitik at Universität Bremen. Supported by Volkswagen
Foundation
32 pages

download: http://med4all.org/index.php?id=14
order print copy:  <mailto:cwagner at bukopharma.de> cwagner at bukopharma.de
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20090424/0104206b/attachment-0001.html>